NLRP3 and inflammatory bowel disease: It modulates the TLR4/TLR2/NF‐κB/STAT3 signalling pathway consequently affecting inflammatory cytokine expression35 and controls inflammatory bowel disease (IBD)‐associated intestinal inflammation by inhibiting NLRP3 inflammasome.36